Latest News
Get real-time updates on the latest news and developments in the pharmaceutical world. Stay informed about new drug launches, research findings, regulatory changes, and industry updates. Explore a wide range of topics and stay connected with the rapidly evolving world of pharma.
ImmunityBio cuts 50 jobs in California and Florida after FDA snubs its bladder cancer drug
Following an FDA rejection earlier this year, ImmunityBio has initiated its second round of layoffs in less than a year, ...
Antios shuts down after FDA halts its hepatitis B drug ATI-2173
Antios Therapeutics, a biotech company focused on viral diseases, ceased its operations earlier this year following an FDA-imposed hold on ...
Glenmark sells API business to Nirma for $681M, wipes out debt
Glenmark Pharmaceuticals has successfully resolved its long-standing debt issue by divesting 75% of its active pharmaceutical ingredient (API) business. The ...
Opdivo plus chemo reduces recurrence risk in early-stage lung cancer surgery
In the arena of perioperative treatment for early-stage non-small cell lung cancer (NSCLC) involving PD-1/L1 inhibitors, the competition among key ...
Padcev-Keytruda combo cuts death risk in first-line bladder cancer
As Seagen readies itself for its impending acquisition by Pfizer, a significant triumph emerges for the company’s cancer drug Padcev, ...
Keytruda-Lenvima combo fails to improve survival in two lung cancer trials
Merck and Eisai’s collaborative effort with Keytruda and Lenvima faces yet another setback in their quest to combat cancer. Despite ...
Jardiance gets FDA green light for chronic kidney disease, challenging AstraZeneca’s rival drug
Shortly after securing European approval for the treatment of chronic kidney disease (CKD), Eli Lilly and Boehringer Ingelheim have achieved ...
Virtual Incision secures $30M funding to expand its mini-robot for laparoscopic surgery
A diminutive robot is making a significant financial stride. Virtual Incision, a pioneer in assisted surgery technology, has secured a ...
AstraZeneca and Daiichi Reach Key Milestone in Breast Cancer ADC Trial, Paving Way to Challenge Gilead
AstraZeneca and Daiichi Sankyo are making a strategic move to challenge Gilead Sciences’ position in the breast cancer arena. They ...
Abpro to go public via SPAC merger with Atlantic Coastal, raising funds for its HER2xCD3 bispecific and COVID-19 program
Abpro is making a return to the public market after a five-year hiatus, this time teaming up with Atlantic Coastal ...
Filspari fails to confirm kidney benefit in IgAN, but Travere hopes to keep FDA approval
Half a year after securing accelerated approval for the treatment of a rare kidney ailment, Travere Therapeutics’ groundbreaking drug, Filspari, ...
NICE approves Lilly’s Omvoh for ulcerative colitis after FDA rejection, citing cost-effectiveness and clinical benefits
“In a significant turn of events, Eli Lilly, despite initial setbacks in the US market with its ulcerative colitis drug ...
COVID variants share common strategy to evade immune system, study finds
The spotlight on SARS-CoV-2, the virus responsible for COVID-19, has primarily focused on its spike protein, crucial for cell entry. ...
Aurinia appoints founder and former CEO Robert Foster to board as part of cooperation agreement with MKT Capital
Aurinia Pharmaceuticals, known for its focus on autoimmune diseases, has taken steps to address investor concerns by appointing its founder ...
Takeda reaches settlement with drug wholesalers over alleged pay-for-delay scheme for Colcrys
Takeda, the Japanese pharmaceutical giant, has reached a settlement in an antitrust case that has been looming over the company. ...
Roche wins patent appeal over Hemlibra, its hemophilia A drug, against Takeda’s Baxalta
In a patent dispute revolving around two competing hemophilia medications, Roche’s Genentech unit has achieved its second consecutive victory. Following ...
Eric Stonestreet, ‘Modern Family’ Actor, Joins Forces with Astellas’ Iveric Bio to Launch Vision Health Awareness Initiative
Iveric Bio, an Astellas-acquired biotech company, has initiated a compelling awareness campaign for a disease it recently gained FDA approval ...
Novo Nordisk Foundation Cellerator to boost cell therapy development and production in Denmark
The Novo Nordisk Foundation is embarking on a mission to establish a pivotal “hub” within the cell therapy ecosystem by ...
Gallup poll shows pharma industry’s reputation plunges to record low amid COVID-19 vaccine criticism
The pharmaceutical industry’s reputation in the United States has reached its lowest point in the 21st century, with a significant ...
Relmada reports positive results from open-label trial of REL-1017 for major depressive disorder
Relmada Therapeutics, a central-nervous-system-focused biotech company, has finally glimpsed a ray of optimism after facing setbacks in two phase 3 ...
Mesoblast hopes to win FDA approval for remestemcel-L after meeting with regulators
Mesoblast, a biotech company based in Melbourne, Australia, is making determined strides toward securing FDA approval for its off-the-shelf therapy, ...
Inventiva and Kezar partner with Asian biotechs to advance NASH and lupus drugs
In a strategic move, Inventiva and Kezar Life Sciences have successfully secured buyers for the Asian rights to their lead ...
Roche fined for serious breach of marketing code by failing to disclose safety data
Roche, a prominent pharmaceutical company, is under scrutiny for omitting vital safety details from a webpage dedicated to dosing information ...
UCB’s psoriasis drug application overcomes manufacturing hurdle but hits another FDA delay
After facing delays related to manufacturing issues, UCB’s psoriasis medication, bimekizumab, is awaiting the next steps in its FDA review ...
Rising Pharmaceuticals opens former Akorn plant to produce sterile injectables and ophthalmics
Rising Pharmaceuticals, a prominent generic drug manufacturer, has inaugurated a manufacturing facility with a specific focus on injectable and ophthalmic ...
FDA denies approval for Neffy, ARS Pharmaceuticals’ needle-free EpiPen alternative, citing safety concerns
While positive votes from FDA advisory committees often bode well for drug approvals, ARS Pharmaceuticals experienced an unexpected setback when ...
Eli Lilly Sues 8 Companies for selling fake Mounjaro versions
The surging demand for GLP-1 diabetes and weight loss medications has led to an inevitable influx of knockoff versions. Earlier ...
Merck KGaA signs two deals with BenevolentAI and Exscientia to boost AI-driven drug discovery in oncology and immunology
Merck KGaA is making strategic moves in the field of AI-enabled drug discovery by entering into three-target partnerships with BenevolentAI ...
Genentech and PeptiDream expand peptide collaboration to explore radiopharmaceuticals for cancer
Japanese biotech firm PeptiDream continues to attract significant interest from major pharmaceutical companies. Genentech, a long-term partner, has entered into ...
Genentech and Orionis Biosciences team up to discover molecular glue drugs for oncology and neurodegeneration
Genentech, a subsidiary of Roche, is aggressively expanding its partnered portfolio into cutting-edge areas of research and development. Following a ...
